Cargando…
Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
One hundred years ago, Dr. Paul Ehrlich popularized the “magic bullet” concept for cancer therapy in which an ideal therapeutic agent would only kill the specific tumor cells it targeted. Since then, “targeted therapy” that specifically targets the molecular defects responsible for a patient's...
Autores principales: | Zhou, Jiehua, Rossi, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078761/ https://www.ncbi.nlm.nih.gov/pubmed/24936916 http://dx.doi.org/10.1038/mtna.2014.21 |
Ejemplares similares
-
Aptamer-targeted cell-specific RNA interference
por: Zhou, Jiehua, et al.
Publicado: (2010) -
Current Advances in Aptamers for Cancer Diagnosis and Therapy
por: Hori, Shin-ichiro, et al.
Publicado: (2018) -
Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma
por: Shum, Ka-To, et al.
Publicado: (2013) -
Aptamer-Based Therapeutics: New Approaches to Combat Human Viral Diseases
por: Shum, Ka-To, et al.
Publicado: (2013) -
Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents
por: Kim, Minhee, et al.
Publicado: (2018)